In the shocking and hilarious documentary ORGASM INC., filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD).
Liz gains permission to film the company for her own documentary. Initially, she plans to create a movie about science and pleasure but she soon begins to suspect that her employer, along with a cadre of other medical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of billion dollar profits. ORGASM INC. is a powerful look inside the medical industry and the marketing campaigns that are literally and figuratively reshaping our everyday lives around health, illness, desire — and that ultimate moment: orgasm.
Viagra, Priligy...ahora llega ORGASM (con algo debajo de...).
Ya estamos completos???
The films were for a drug company called Vivus, which was developing an 'orgasm cream' to boost women's sex lives.
.../...
Orgasm Inc follows Liz on a nine year journey as she meets CEOs of drug companies, researchers, doctors, scientists and therapists - all claiming to hold the key to the ultimate female sexual experience.
One doctor in the U.S. has invented a machine he called an ' Orgasmatron', which inserts electrodes into the spine and can be operated at the touch of a button for, so it claims, an instant climax 'in the car, while you're doing housework - anywhere you like'.
The Orgasmatron started life as a fictional device in the 1968 film Barbarella and early Woody Allen movie, Sleeper.
Other companies are developing a wide range of drug treatments that work on everything from brain chemistry to hormones, delivered in a series of pills, nasal sprays, chewing gums, patches and potions.Female Sexual Dysfunction is a new 'disease' that has been created by drug companies, she insists, ' because if they can convince us it's an illness, they can sell us a cure'.
Ver...
No hay comentarios:
Publicar un comentario